Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Bin Liu
Introduction
Bin Liu is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on innovative approaches to treating tumors. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Bin Liu's latest patents include groundbreaking research on macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics. These patents provide methods for utilizing human anti-CD46 antibodies that can internalize and enter tumor cells through the macropinocytosis pathway. Additionally, he has developed antibody-drug conjugates (ADCs) derived from these antibodies for the diagnostic and therapeutic targeting of CD46-overexpressing tumors. Another significant patent details methods for treating cancers characterized by a modification at biomarker 1q21, which involves administering a therapeutically effective amount of an anti-CD46 antibody to the subject.
Career Highlights
Bin Liu is affiliated with the University of California, where he continues to push the boundaries of cancer research. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from various forms of cancer.
Collaborations
He collaborates with esteemed colleagues such as Yang Su and Christopher R Behrens, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Bin Liu's contributions to the field of cancer therapeutics exemplify the impact of innovative research on medical science. His patents and collaborative efforts are paving the way for new treatment modalities that could significantly benefit patients in the future.